My watch list
my.chemeurope.com  
Login  

TCH346



TCH346 is a drug in clinical trials to help treat Amyotrophic Lateral Sclerosis (ALS)

External Reference

  • Neurological Institute of New York Columbia University
  • National Center for Biotechnology Information article


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "TCH346". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE